C.E. Roeper GmbH
Groß- und Außenhandel von natürlichen Rohstoffen
Documents Up to Date
Catalog
Documents
CEROGA Sodium Alginate 110-270 mPas / 60 mesh Tye NA 1127
Documents Up to Date
Locations
| Location name | Address |
|---|---|
| C.E. ROEPER GMBH - Lucid Colloids Ltd | Plot No 757/1, GIDC BHARUCH, GJ 393110 IND |
| C.E. Roeper GmbH (corporate) | Hans-Duncker-Str. 13 Hamburg, HH 21035 DEU |
Documents
| Type | Location | File name | Effective | Expiration |
|---|---|---|---|---|
| Food Defense Plan Statement | Deosen Biochemical (Ordos)Ltd. (via. Roeper) | BRC_2024_11_06_Deosen.pdf | 5/29/2024 | 5/29/2026 |
| Recall Plan | Deosen Biochemical (Ordos)Ltd. (via. Roeper) | BRC_2024_11_06_Deosen.pdf | 5/29/2024 | 5/29/2025 |
| Zentis Mutual ND-Confidentiality Agreement | C.E. Roeper GmbH (corporate) | confidentiality agreement.pdf | 5/16/2024 | 5/16/2034 |
| Zentis Supplier Insurance and Indemnification | C.E. Roeper GmbH (corporate) | Document.pdf | 4/22/2025 | 4/22/2026 |
| Recall/Emergency/Contact List | C.E. Roeper GmbH (corporate) | Emergency_crisis_contact.pdf | 2/12/2025 | 2/12/2026 |
| FDA Registration | C.E. Roeper GmbH (corporate) | FDA registration statement update.pdf | 11/27/2024 | 11/27/2025 |
| Food Defense Plan Statement | C.E. Roeper GmbH (corporate) | Food Defence Statement 11593.pdf | 4/2/2024 | 4/2/2026 |
| HARPC Food Safety Plan (Facility) | C.E. Roeper GmbH (corporate) | Food Safety Statement (2).pdf | 1/7/2025 | 11/25/2025 |
| GFSI Audit Report | C.E. Roeper GmbH (corporate) | IFSBroker_V3.2_en_2026_04_09.pdf | 3/12/2025 | 4/9/2026 |
| GFSI Certificate | Deosen Biochemical (Ordos)Ltd. (via. Roeper) | IFSBroker_V3.2_en_2026_04_09.pdf | 3/12/2025 | 4/9/2026 |
| GFSI Certificate | C.E. Roeper GmbH (corporate) | IFSBroker_V3.2_en_2026_04_09.pdf | 3/12/2025 | 4/9/2026 |
| 3rd Party Audit Certificate | C.E. Roeper GmbH (corporate) | IFSBroker_V3.2_en_2026_04_09.pdf | 3/12/2025 | 4/9/2026 |
| Bioterrorism Letter | C.E. Roeper GmbH (corporate) | ISO22000.pdf | 10/17/2024 | 10/17/2026 |
| 3rd Party Audit Report | C.E. Roeper GmbH (corporate) | NotApplicable_3rdPartyAuditReport.pdf | 11/4/2024 | 11/4/2025 |
| FSVP Assessment Form Supporting Document | C.E. Roeper GmbH (corporate) | NotApplicable_FSVPAssessmentFormSupportingDocument.pdf | 3/4/2025 | 3/4/2027 |
| Letter of Guarantee | C.E. Roeper GmbH (corporate) | NotApplicable_LetterofGuarantee.pdf | 11/4/2024 | 11/4/2026 |
| Recall Plan | C.E. Roeper GmbH (corporate) | NotApplicable_RecallPlan.pdf | 3/5/2025 | 3/5/2026 |
| W-9 | C.E. Roeper GmbH (corporate) | NotApplicable_W9.pdf | 3/3/2025 | 3/2/2028 |
| Producers List | C.E. Roeper GmbH (corporate) | Producer statement Xanthan 10215 ex Deosen.pdf | 3/25/2024 | 3/25/2026 |
| GFSI Corrective Action | C.E. Roeper GmbH (corporate) | QGGO_Auditreport_2024_2025.pdf | 1/7/2025 | 11/13/2025 |
| Insurance | C.E. Roeper GmbH (corporate) | QGGO_Auditreport_2024_2025.pdf | 1/7/2025 | 11/13/2025 |
| Zentis Supplier Code of Conduct | C.E. Roeper GmbH (corporate) | Roeper's Social charta signed 20230309.pdf | 4/2/2024 | 4/2/2027 |
| Ethical Code of Conduct | C.E. Roeper GmbH (corporate) | Social Charta_signed.pdf | 4/18/2024 | 4/18/2026 |
| Zentis Safe Raw Material Continuous Guarantee | C.E. Roeper GmbH (corporate) | Specification_guarantee_11593.pdf | 3/3/2025 | 3/3/2026 |
| Supplier Approval Program Statement | C.E. Roeper GmbH (corporate) | Supplier Approval Statement_11593.pdf | 3/5/2025 | 3/5/2026 |
| Supplier Questionnaire EU/UK | Deosen Biochemical (Ordos)Ltd. (via. Roeper) | Supplier Questionnaire EU/UK.pdf | 8/16/2024 | 8/16/2026 |
| Supplier Questionnaire | C.E. Roeper GmbH (corporate) | Supplier Questionnaire.pdf | 5/29/2024 | 5/29/2026 |
| Supplier Questionnaire | Deosen Biochemical (Ordos)Ltd. (via. Roeper) | Supplier Questionnaire.pdf | 8/15/2024 | 8/15/2026 |
| Sustainability (Level 1) | C.E. Roeper GmbH (corporate) | Sustainability (Level 1).pdf | 4/2/2024 | 4/2/2027 |
| Zentis General Specification | C.E. Roeper GmbH (corporate) | TDS_11593_Version3_still valid.pdf | 3/5/2025 | 3/5/2026 |
| HACCP Plan (Facility) | Deosen Biochemical (Ordos)Ltd. (via. Roeper) | VA 4.1 - 2 Risikomanagement-HACCP-Konzept Praxis Rev. 16 - 24.08.2023.pdf | 5/24/2024 | 5/24/2026 |
| Allergen Control Policy | Deosen Biochemical (Ordos)Ltd. (via. Roeper) | VA 4.1 - 2 Risikomanagement-HACCP-Konzept Praxis Rev. 16 - 24.08.2023.pdf | 5/24/2024 | 5/24/2026 |
| Allergen Control Policy | C.E. Roeper GmbH (corporate) | VA 4.1 - 2 Risikomanagement-HACCP-Konzept Praxis Rev. 16 - 24.08.2023.pdf | 8/24/2023 | 8/23/2025 |
| HACCP Plan (Facility) | C.E. Roeper GmbH (corporate) | VA 4.1 - 2 Risikomanagement-HACCP-Konzept Praxis Rev. 16 - 24.08.2023.pdf | 8/24/2024 | 8/24/2026 |